Assessment of single-vessel cerebral blood velocity by phase contrast fMRI.


Journal

PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755

Informations de publication

Date de publication:
09 2021
Historique:
received: 17 08 2020
accepted: 28 07 2021
revised: 21 09 2021
pubmed: 10 9 2021
medline: 20 11 2021
entrez: 9 9 2021
Statut: epublish

Résumé

Current approaches to high-field functional MRI (fMRI) provide 2 means to map hemodynamics at the level of single vessels in the brain. One is through changes in deoxyhemoglobin in venules, i.e., blood oxygenation level-dependent (BOLD) fMRI, while the second is through changes in arteriole diameter, i.e., cerebral blood volume (CBV) fMRI. Here, we introduce cerebral blood flow-related velocity-based fMRI, denoted CBFv-fMRI, which uses high-resolution phase contrast (PC) MRI to form velocity measurements of flow. We use CBFv-fMRI in measure changes in blood velocity in single penetrating microvessels across rat parietal cortex. In contrast to the venule-dominated BOLD and arteriole-dominated CBV fMRI signals, CBFv-fMRI is comparable from both arterioles and venules. A single fMRI platform is used to map changes in blood pO2 (BOLD), volume (CBV), and velocity (CBFv). This combined high-resolution single-vessel fMRI mapping scheme enables vessel-specific hemodynamic mapping in animal models of normal and diseased states and further has translational potential to map vascular dementia in diseased or injured human brains with ultra-high-field fMRI.

Identifiants

pubmed: 34499636
doi: 10.1371/journal.pbio.3000923
pii: PBIOLOGY-D-20-02507
pmc: PMC8454982
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3000923

Subventions

Organisme : NINDS NIH HHS
ID : R35 NS097265
Pays : United States
Organisme : NINDS NIH HHS
ID : RF1 NS113278
Pays : United States
Organisme : NINDS NIH HHS
ID : U19 NS123717
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS120594
Pays : United States
Organisme : NIMH NIH HHS
ID : S10 MH124733
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH111438
Pays : United States
Organisme : NIH HHS
ID : S10 OD028616
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS121642
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS122904
Pays : United States

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1834-9
pubmed: 9465103
Neuroimage. 2007 Jul 15;36(4):1110-22
pubmed: 17524665
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8473-8
pubmed: 21536897
J Neurotrauma. 2011 Mar;28(3):359-69
pubmed: 21190398
Nat Neurosci. 2007 May;10(5):549-51
pubmed: 17417634
Neuron. 2017 Nov 15;96(4):936-948.e3
pubmed: 29107517
Front Neurosci. 2020 May 05;14:415
pubmed: 32431591
Science. 1991 Nov 1;254(5032):716-9
pubmed: 1948051
J Cereb Blood Flow Metab. 2007 Apr;27(4):839-49
pubmed: 16969383
Magn Reson Imaging. 1982;1(4):197-203
pubmed: 6927206
Magn Reson Med. 2003 Aug;50(2):263-74
pubmed: 12876702
Magn Reson Med. 2019 Apr;81(4):2566-2575
pubmed: 30393888
Nat Methods. 2010 Dec;7(12):981-4
pubmed: 20966916
Magn Reson Med. 1999 Mar;41(3):520-8
pubmed: 10204875
Magn Reson Med. 1992 Jan;23(1):37-45
pubmed: 1734182
J Magn Reson Imaging. 1993 May-Jun;3(3):521-30
pubmed: 8324312
Magn Reson Med. 1998 Feb;39(2):300-8
pubmed: 9469714
Magn Reson Imaging. 2016 Jul;34(6):754-764
pubmed: 26968145
J Neurosci. 2016 Jan 27;36(4):1261-72
pubmed: 26818514
Clin Neurophysiol. 2002 May;113(5):621-34
pubmed: 11976042
Neuron. 2020 Feb 5;105(3):549-561.e5
pubmed: 31810839
Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):5951-5
pubmed: 1631079
J Cereb Blood Flow Metab. 2007 Apr;27(4):831-8
pubmed: 16926843
J Biomed Opt. 2011 Oct;16(10):106014
pubmed: 22029361
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5675-9
pubmed: 1608978
J Comput Assist Tomogr. 1984 Aug;8(4):588-93
pubmed: 6736356
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15741-6
pubmed: 9861040
Photoacoustics. 2019 Dec 26;17:100153
pubmed: 32154103
Neuron. 2018 Jul 25;99(2):362-375.e4
pubmed: 29937277
Nature. 2010 Nov 11;468(7321):232-43
pubmed: 21068832
Magn Reson Med. 2008 Dec;60(6):1284-91
pubmed: 19030161
Magn Reson Med. 2005 Jan;53(1):126-33
pubmed: 15690511
Neuron. 2018 Feb 21;97(4):925-939.e5
pubmed: 29398359
Neuroimage. 2018 May 15;172:470-477
pubmed: 29408324
Neuroimage. 2019 Jul 15;195:463-474
pubmed: 30935910
Opt Express. 2009 Aug 3;17(16):13354-64
pubmed: 19654740
Neuroimage. 2006 Aug 15;32(2):520-30
pubmed: 16713717
Neuroimage. 2012 Aug 15;62(2):602-7
pubmed: 22245338
J Cereb Blood Flow Metab. 2001 Mar;21(3):195-201
pubmed: 11295873
Magn Reson Med. 2006 Jun;55(6):1334-41
pubmed: 16700025
Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):212-6
pubmed: 1729691
Neuroimage. 1999 Dec;10(6):716-23
pubmed: 10600417
Magn Reson Med. 2007 Jun;57(6):1110-8
pubmed: 17534912
Nat Neurosci. 2013 Jan;16(1):55-63
pubmed: 23242312
Nat Commun. 2019 Nov 20;10(1):5239
pubmed: 31748553
Nat Methods. 2011 Jul 03;8(8):662-4
pubmed: 21725300
Nat Methods. 2016 Apr;13(4):337-40
pubmed: 26855362
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9868-72
pubmed: 2124706
Nat Methods. 2015 Sep;12(9):831-4
pubmed: 26237228
J Cereb Blood Flow Metab. 2012 Jul;32(7):1277-309
pubmed: 22293983
PLoS Biol. 2006 Feb;4(2):e22
pubmed: 16379497
Magn Reson Med. 2016 Apr;75(4):1640-6
pubmed: 25980462
Neuron. 2017 Dec 20;96(6):1253-1263.e7
pubmed: 29224727
J Cereb Blood Flow Metab. 2016 Jul;36(7):1244-56
pubmed: 27142868
Opt Lett. 2009 Oct 15;34(20):3086-8
pubmed: 19838234
Intravital. 2014 May;3(2):
pubmed: 25568834
Front Physiol. 2017 Nov 24;8:961
pubmed: 29225580
Fluids Barriers CNS. 2011 Jan 18;8(1):5
pubmed: 21349153
NMR Biomed. 2016 Sep;29(9):1295-304
pubmed: 25916399
Elife. 2020 Jan 30;9:
pubmed: 31999253
Opt Lett. 2010 May 1;35(9):1419-21
pubmed: 20436589
Nat Commun. 2017 Jan 31;8:14191
pubmed: 28139643

Auteurs

Xuming Chen (X)

High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Department of Neurology, Wuhan University, Renmin Hospital, Wuhan, China.

Yuanyuan Jiang (Y)

Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America.

Sangcheon Choi (S)

High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Graduate Training Centre of Neuroscience, International Max Planck Research School, University of Tübingen, Tübingen, Germany.

Rolf Pohmann (R)

High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.

Klaus Scheffler (K)

High-Field Magnetic Resonance, Max Planck Institute for Biological Cybernetics, Tübingen, Germany.
Department for Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany.

David Kleinfeld (D)

Department of Physics, University of California at San Diego, La Jolla, California, United States of America.
Section of Neurobiology, University of California at San Diego, La Jolla, California, United States of America.

Xin Yu (X)

Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, United States of America.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH